Management of heart failure in elderly people

International Journal of Clinical Practice

Volumn 62, Issue 2, 2008, Pages 270-280

  Imazio, M ^a   Cotroneo, A ^b   Gaschino, G ^a   Chinaglia, A ^a   Gareri, P ^c   Lacava, R ^c   Voci, T D ^d   Trinchero, R ^a  

^a MARIA VITTORIA HOSPITAL   (Italy)

^b Birago di Vische Hospital   (Italy)

^c Geriatric Department   (Italy)

^d National Association of Ambulatory Cardiology and Medicine (ACSA Onlus)   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; METOPROLOL; NONSTEROID ANTIINFLAMMATORY AGENT;

AGING; ANEMIA; ANTICOAGULANT THERAPY; ARTHRITIS; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CHRONIC DISEASE; CHRONIC LUNG DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; COMORBIDITY; DEFIBRILLATOR; DEPRESSION; DIABETES MELLITUS; DIAGNOSTIC PROCEDURE; DIASTOLIC HEART FAILURE; DIETARY INTAKE; DISEASE COURSE; DISEASE SEVERITY; DYSLIPIDEMIA; ECHOCARDIOGRAPHY; ELDERLY CARE; HEALTH BEHAVIOR; HEALTH CARE COST; HEALTH PROGRAM; HEALTH SERVICE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE CONDUCTION DISTURBANCE; HEART MUSCLE REVASCULARIZATION; HEART OUTPUT; HEART PERFORMANCE; HEART RATE; HEART VENTRICLE CONTRACTION; HOSPITALIZATION; HUMAN; HYPERTENSION; HYPOTENSION; ISCHEMIC HEART DISEASE; KIDNEY DISEASE; KIDNEY FUNCTION; LIFESTYLE MODIFICATION; NUTRITIONAL ASSESSMENT; NUTRITIONAL DISORDER; OUTCOME ASSESSMENT; PACEMAKER; PALLIATIVE THERAPY; PATIENT ATTITUDE; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK ASSESSMENT; RISK REDUCTION; SENSORY DYSFUNCTION; SEX DIFFERENCE; SINUS RHYTHM; SURVIVAL RATE; SURVIVAL TIME; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT PLANNING; WEIGHT CONTROL;

ADRENERGIC BETA-ANTAGONISTS; AGE FACTORS; AGED; AGING; ATRIAL FIBRILLATION; CARDIAC PACING, ARTIFICIAL; COMORBIDITY; EVIDENCE-BASED MEDICINE; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; PATIENT CARE TEAM;

EID: 38149021573     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2007.01583.x     Document Type: Review

References (98)

1. Linne AB, Liedholm H, Jendteg S, Israelsson B. Health care costs of heart failure: results from a randomized study of patient education. Eur J Heart Fail 2002 2 : 291 7.
2. DiLenarda A, Scherillo M, Maggioni AP et al. Current presentation and management of heart failure in cardiology and internal medicine hospital units: a tale of two worlds - the TEMISTOCLE study. Am Heart J 2003 146 : E12.
3. Heiat A, Gross CP, Krumholz HM. Representation of the elderly, women, and minorities in heart failure clinical trials. Arch Intern Med 2002 162 : 1682 8.
4. Lee DS, Austin PC, Rouleau JL et al. Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model. JAMA 2003 290 : 2581 7.
5. Fraticelli A, Gesuita R, Vespa A, Paciaroni E. Congestive heart failure in the elderly requiring hospital admission. Arch Gerontol Geriatr 1996 23 : 225 38.
6. Redfield MM, Karon BL, Jacobsen SJ, Rodeheffer RJ. Effect of age on vascular function, LV structure and systolic and diastolic ventricular function in the adult population. J Card Fail 2004 10 (Suppl. 1) : S34.
7. Kawaguchi M, Hay I, Fetics B, Kass DA. Combined ventricular systolic and arterial stiffening in patients with heart failure and preserved ejection fraction: implications for systolic and diastolic reserve limitations. Circulation 2003 107 : 714 20.
8. Sclater A, Alagiakrishnan K. Orthostatic hypotension. A primary care primer for assessment and treatment. Geriatrics 2004 59 : 22 7.
9. Chae CU, Albert CM, Glynn RJ et al. Mild renal insufficiency and risk of congestive heart failure in men and women ≥ 70 years of age. Am J Cardiol 2003 92 : 682 6.
10. Braunstein JB, Anderson GF, Gerstenblith G et al. Noncardiac comorbidity increases preventable hospitalizations and mortality among Medicare beneficiaries with chronic heart failure. J Am Coll Cardiol 2003 42 : 1226 33.
11. Rich MW. Heart failure in the oldest patients: the impact of comobid conditions. AJGC 2005 14 : 134 41.
12. McClellan WM, Flanders WD, Langston RD et al. Anemia and renal insufficiency are independent risk factors for death among patients with congestive heart failure admitted to community hospitals: a population-based study. J Am Soc Nephrol 2002 13 : 1928 36.
13. Krumholz HM, Chen YT, Vaccarino V et al. Correlates and impact on outcomes of worsening renal function in patients ≥ 65 years of age with heart failure. Am J Cardiol 2000 85 : 1110 3.
14. Kosiborod M, Smith GL, Radford MJ et al. The prognostic importance of anemia in patients with heart failure. Am J Med 2003 114 : 112 9.
15. Redfield MM, Rodeheffer RJ, Jacobsen SJ et al. Plasma brain natriuretic peptide concentration: impact of age and gender. J Am Coll Cardiol 2002 40 : 976 82.
16. Krumholz HM, Butler J, Miller J et al. Prognostic importance of emotional support for elderly patients hospitalized with heart failure. Circulation 1998 97 : 958 64.
17. Vaccarino V, Kasl SV, Abramson J, Krumholz HM. Depressive symptoms and risk of functional decline and death in patients with heart failure. J Am Coll Cardiol 2001 38 : 199 205.
18. Page J, Henry D. Consumption of NSAIDs and the development of congestive heart failure in elderly patients: an underrecognized public health problem. Arch Intern Med 2000 160 : 777 84.
19. McGann PE. Comorbidity in heart failure in the elderly. Clin Geriatr Med 2000 16 : 631 48.
20. Persson MD, Brismar KE, Katzarski KS et al. Nutritional status using mini nutritional assessment and subjective global assessment predict mortality in geriatric patients. J Am Geriatr Soc 2002 50 : 1996 2002.
21. Vogels RL, Scheltens P, Schroeder-Tanka JM, Weinstein HC. Cognitive impairment in heart failure: a systematic review of the literature. Eur J Heart Fail 2007 9 : 440 9.
22. Zuckerman JD. Hip fractures. N Engl J Med 1996 334 : 1519 25.
23. Swedberg K, Cleland J, Dargie H et al. Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 2005 26 : 1115 40.
24. Hunt SA, Abraham WT, Chin MH et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 2005 112 : 0e154 235.
25. Maisel AS, Krishnaswamy P, Nowak RM et al. Breathing Not Properly Multinational Study Investigators. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002 347 : 161 7
26. Flather MD, Shibata MC, Coats AJ et al. SENIORS Investigators. Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J 2005 26 : 215 25.
27. McMurray J. Making sense of SENIORS. Eur Heart J 2005 26 : 203 6.
28. Lindsey ML, Freeman GL. Beta-blockade in heart failure: adding SENIORS to the mix. Eur Heart J 2006 27 : 506 7.
29. Herzog AR, Fultz NH. Prevalence and incidence of urinary incontinence in community-dwelling populations. J Am Geriatr Soc 1990 38 : 273 81.
30. Anger JT, Saigal CS, Litwin MS. The prevalence of urinary incontinence among community dwelling adult women: results from the National Health and Nutrition Examination Survey. J Urol 2006 175 : 601 4.
31. DuBeau CE. Interpreting the effect of common medical conditions on voiding dysfunction in the elderly. Urol Clin North Am 1996 23 : 11 8.
32. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure(MERIT-HF). Lancet 1999 353 : 2001 7.
33. Deedwania PC, Gottlieb S, Ghali JK et al. Efficacy, safety and tolerability of beta-adrenergic blockade with metoprolol CR/XL in elderly patients with heart failure. Eur Heart J 2004 25 : 1300 9.
34. Packer M, Bristow MR, Cohn JN et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. N Engl J Med 1996 334 : 1349 55.
35. Sin DD, McAlister FA. The effects of beta-blockers on morbidity and mortality in a population-based cohort of 11,942 elderly patients with heart failure. Am J Med 2002 113 : 650 6.
36. Lernfelt B, Landahl S, Svanborg A. Coronary heart disease at 70, 75 and 79 years of age: a longitudinal study with special reference to sex differences and mortality. Age Ageing 1990 19 : 297 303.
37. Kurita A, Takase B, Uehata A et al. Painless myocardial ischemia in elderly patients compared with middle-aged patients and its relation to treadmill testing and coronary hemodynamics. Clin Cardiol 1991 14 : 886 90.
38. LaCroix AZ, Guralnik JM, Curb JD et al. Chest pain and coronary heart disease mortality among older men and women in three communities. Circulation 1990 81 : 437 46.
39. Fox K, Garcia MA, Ardissino D et al. Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology; ESC Committee for Practice Guidelines (CPG). Guidelines on the management of stable angina pectoris: executive summary: the Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Eur Heart J 2006 27 : 1341 81.
40. Phillips HR, O'Connor CM, Rogers J. Revascularization for heart failure. Am Heart J 2007 153 : S65 73.
41. Gundersen T, Abrahamsen AM, Kjekshus J, Ronnevik PK. Timolol-related reduction in mortality and reinfarction in patients ages 65-75 years surviving acute myocardial infarction. Prepared for the Norwegian Multicentre Study Group. Circulation 1982 66 : 1179 84.
42. Metzger JP, Tabone X, Georges JL et al. Coronary angioplasty in patients 75 years and older; comparison with coronary bypass surgery. Eur Heart J 1994 15 : 213 7.
43. Bonnier H, de Vries C, Michels R, el Gamal M. Initial and long-term results of coronary angioplasty and coronary bypass surgery in patients of 75 or older. Br Heart J 1993 70 : 122 5.
44. Wenger NK, Helmy T, Patel AD, Lerakis S. Evidence-based management of coronary artery disease in the elderly - current perspectives. Med Gen Med 2005 7 : 75.
45. Zile MR, Brutsaert DL. New concepts in diastolic dysfunction and diastolic heart failure: Part I: diagnosis, prognosis, and measurements of diastolic function. Circulation 2002 105 : 1387 93.
46. Topol EJ, Traill TA, Fortuin NJ. Hypertensive hypertrophic cardiomyopathy of the elderly. N Engl J Med 1985 312 : 277 83.
47. Gottdiener JS, McClelland RL, Marshall R et al. Outcome of congestive heart failure in elderly persons: influence of left ventricular systolic function. The Cardiovascular Health Study. Ann Intern Med 2002 137 : 631 9.
48. Kitzman DW, Sheikh KH, Beere PA et al. Age-related alterations of Doppler left ventricular filling indexes in normal subjects are independent of left ventricular mass, heart rate, contractility and loading conditions. J Am Coll Cardiol 1991 18 : 1243 50.
49. Masoudi FA, Havranek EP, Smith G et al. Gender, age, and heart failure with preserved left ventricular systolic function. J Am Coll Cardiol 2003 41 : 217 23.
50. Redfield MM, Jacobsen SJ, Burnett Jr. JC et al. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 2003 289 : 194 202.
51. Mancini DM, Henson D, LaManca J et al. Respiratory muscle function and dyspnea in patients with chronic congestive heart failure. Circulation 1992 86 : 909 18.
52. Klingbeil AU, Schneider M, Martus P, Messerli FH. A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension. Am J Med 2003 115 : 41 6.
53. Caruana L, Petrie MC, Davie AP, McMurray JJ. Do patients with suspected heart failure and preserved left ventricular systolic function suffer from ''diastolic heart failure'' or from misdiagnosis? A prospective descriptive study. BMJ 2000 321 : 215 8.
54. Vasan RS, Larson MG, Benjamin EJ et al. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol 1999 33 : 1948 55.
55. Cohn JN, Johnson G Veterans Administration Cooperative Study Group. Heart failure with normal ejection fraction. The V-HeFT Study. Circulation 1990 81 (2 suppl 0III48 53.
56. Jones RC, Francis GS, Lauer MS. Predictors of mortality in patients with heart failure and preserved systolic function in the Digitalis Investigation Group trial. J Am Coll Cardiol 2004 44 : 1025 9.
57. Senni M, Redfield MM. Heart failure with preserved systolic function. A different natural history J Am Coll Cardiol 2001 38 : 1277 82.
58. Gohler A, Januzzi JL, Worrell SS et al. A systematic meta-analysis of the efficacy and heterogeneity of disease management programs in congestive heart failure. J Card Fail 2006 12 : 554 67.
59. Go AS, Hylek EM, Phillips KA et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001 285 : 2370 5.
60. Heeringa J, van der Kuip DA, Hofman A et al. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J 2006 27 : 949 53.
61. Carson PE, Johnson GR, Dunkman WB et al. The influence of atrial fibrillation on prognosis in mild to moderate heart failure. The V-HeFT Studies. The V-HeFT VA Cooperative Studies Group. Circulation 1993 87 (6 Suppl VI102 10.
62. Stevenson WG, Stevenson LW, Middlekauff HR et al. Improving survival for patients with atrial fibrillation and advanced heart failure. J Am Coll Cardiol 1996 28 : 1458 63.
63. Dries DL, Exner DV, Gersh BJ et al. Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. Studies of Left Ventricular Dysfunction. J Am Coll Cardiol 1998 32 : 695 703.
64. Benjamin EJ, Levy D, Vaziri SM et al. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA 1994 271 : 840 4.
65. Khand AU, Rankin AC, Kaye GC, Cleland JG. Systematic review of the management of atrial fibrillation in patients with heart failure. Eur Heart J 2000 21 : 614 32.
66. Rationale and design of a study assessing treatment strategies of atrial fibrillation in patients with heart failure: the Atrial Fibrillation and Congestive Heart Failure (AF-CHF) trial. Am Heart J 2002 144 : 597 607.
67. Wyse DG, Waldo AL, DiMarco JP et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002 347 : 1825 33.
68. Van Gelder IC, Hagens VE, Bosker HA et al. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 2002 347 : 1834 40.
69. Man-Son-Hing M, Laupacis A. Anticoagulant-related bleeding in older persons with atrial fibrillation: physicians' fears often unfounded. Arch Intern Med 2003 163 : 1580 6.
70. Nasr IA, Bouzamondo A, Hulot JS et al. Prevention of atrial fibrillation onset by beta-blocker treatment in heart failure: a meta-analysis. Eur Heart J 2007 28 : 457 62.
71. Brignole M, Menozzi C, Gianfranchi L et al. Assessment of atrioventricular junction ablation and VVIR pacemaker versus pharmacological treatment in patients with heart failure and chronic atrial fibrillation: a randomized, controlled study. Circulation 1998 98 : 953 60.
72. Wilkoff BL, Cook JR, Epstein AE et al. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. JAMA 2002 288 : 3115 23.
73. Leclercq C, Kass DA. Retiming the failing heart: principles and current clinical status of cardiac resynchronization. J Am Coll Cardiol 2002 39 : 194 201.
74. Auricchio A, Abraham WT. Cardiac resynchronization therapy: current state of the art: cost versus benefit. Circulation 2004 109 : 300 7.
75. Leclercq C, Hare JM. Ventricular resynchronization: current state of the art. Circulation 2004 109 : 296 9.
76. Martinez C, Tzur A, Hrachian H et al. Pacemakers and defibrillators: recent and ongoing studies that impact the elderly. Am J Geriatr Cardiol 2006 15 : 82 7.
77. Gregoratos G, Abrams J, Epstein AE et al. ACC/AHA/NASPE 2002 Guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (ACC/AHA/NASPE committee to update the 1998 pacemaker guidelines). Circulation 2002 106 : 2145 61.
78. Healey JS, Yee R, Tang A. Right ventricular apical pacing: a necessary evil Curr Opin Cardiol 2007 22 : 33 8.
79. Leclercq C, Kass DA. Retiming the failing heart: principles and current clinical status of cardiac resynchronization. J Am Coll Cardiol 2002 39 : 194 201.
80. Sweeney MO, Ellenbogen KA, Miller EH et al. The Managed Ventricular pacing versus VVI 40 Pacing (MVP) Trial: clinical background, rationale, design, and implementation. J Cardiovasc Electrophysiol 2006 17 : 1295 8.
81. Martin DO, Stolen KQ, Brown S et al. Pacing Evaluation-Atrial SUpport Study in Cardiac Resynchronization Therapy (PEGASUS CRT): design and rationale. Am Heart J 2007 153 : 7 13.
82. Connonlly SJ, Hallstrom AP, Cappato R et al. Meta analysis of the implantable cardioverter defibrillator secondary prevention trials: on behalf of the investigators of the AVID, CASH, and CIDS studies. Eur Heart J 2000 21 : 2071 8.
83. Zipes DP, Camm AJ, Borggrefe M et al. American College of Cardiology/American Heart Association Task Force; European Society of Cardiology Committee for Practice Guidelines; European Heart Rhythm Association; Heart Rhythm Society. ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006 114 : 0e385 484.
84. Huang DT, Sesselberg H, Salam T et al. Survival benefits associated with defibrillator implant in elderly patients enroled I MADIT II. Circulation 2003 108 (Suppl. IV 386.
85. Konstam V, Moser DK, DeJong MJ. Depression and anxiety in heart failure. J Card Fail 2005 11 : 455 63.
86. Rutledge T, Reis VA, Linke SE, Greenberg BH, Mills PJ. Depression in heart failure a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes. J Am Coll Cardiol 2006 48 : 1527 37.
87. Jiang W, Kuchibhatla M, Clary GL et al. Relationship between depressive symptoms and long-term mortality in patients with heart failure. Am Heart J 2007 154 : 102 8.
88. Stuart B. Palliative care and hospice in advanced heart failure. J Palliat Med 2007 10 : 210 28.
89. Cohen HW, Gibson G, Alderman MH. Excess risk of myocardial infarction in patients treated with antidepressant medications: association with use of tricyclic agents. Am J Med 2000 108 : 2 8.
90. Gareri P, Falconi U, De Fazio P, De Sarro G. Conventional and new antidepressant drugs in the elderly. Prog Neurobiol 2000 61 : 353 96.
91. Hippisley-Cox J, Pringle M, Hammersley V et al. Antidepressants as risk factor for ischaemic heart disease: case-control study in primary care. BMJ 2001 323 : 666 9.
92. Hirsch M, Birnbaum RJ. Antidepressant medication in adults: tricyclics and tetracyclics. In : Rose BD, ed. UptoDate Online. Wellesley: Massachusetts, UptoDate, 2007. http://www.uptodate.com (accessed August 2007).
93. Pantilat SZ, Steimle AE. Palliative care for patients with heart failure. JAMA 2004 291 : 2476 82.
94. Goodlin SJ. Palliative care for end-stage heart failure. Curr Heart Fail Rep 2005 2 : 155 60.
95. Kirby D, Ames D. Hyponatraemia and selective serotonin re-uptake inhibitors in elderly patients. Int J Geriatr Psychiatry 2001 16 : 484 93.
96. Katon W, Lin EH, Kroenke K. The association of depression and anxiety with medical symptom burden in patients with chronic medical illness. Gen Hosp Psychiatry 2007 29 : 147 55.
97. Johnson MJ. Management of end stage cardiac failure. Postgrad Med J 2007 83 : 395 401.
98. Selman L, Harding R, Beynon T et al. Improving end-of-life care for patients with chronic heart failure: ''Let's hope it'll get better, when I know in my heart of hearts it won't''. Heart 2007 93 : 963 7.